{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:50:43Z","timestamp":1793944243774,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":528,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA046592"],"award-info":[{"award-number":["P30CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41379-021-00803-z","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:03:10Z","timestamp":1618365790000},"page":"1596-1607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Xiao-Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6642-0468","authenticated-orcid":false,"given":"Rahul","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Skala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Rangaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Chinnaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Zelenka-Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"McMurry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R.","family":"Sangoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravana M.","family":"Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-8884","authenticated-orcid":false,"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00803-z_bib1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5858\/arpa.2016-0218-RA","article-title":"Morphologic, molecular, and taxonomic evolution of renal cell carcinoma: a conceptual perspective with emphasis on updates to the 2016 World Health Organization Classification","volume":"140","author":"Udager","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00803-z_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00803-z_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrurol.2014.162","article-title":"Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers","volume":"11","author":"Kauffman","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1038\/s41379-021-00803-z_bib4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/arpa.2015-0196-RA","article-title":"MiT family translocation-associated renal cell carcinoma: a contemporary update with emphasis on morphologic, immunophenotypic, and molecular mimics","volume":"139","author":"Magers","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00803-z_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/modpathol.2013.208","article-title":"Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage","volume":"27","author":"Ellis","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-019-1297-6","article-title":"Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series","volume":"36","author":"Kennedy","year":"2019","journal-title":"Med Oncol"},{"key":"10.1038\/s41379-021-00803-z_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research, N.","year":"2013","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00803-z_bib11","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-021-00803-z_bib12","doi-asserted-by":"crossref","unstructured":"Argani P, Hicks J, De Marzo AM, Albadine R, Illei PB, Ladanyi M, et al. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34:1295\u20131303.","DOI":"10.1097\/PAS.0b013e3181e8ce5b"},{"key":"10.1038\/s41379-021-00803-z_bib13","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000203","article-title":"t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","article-title":"Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas","volume":"22","author":"Martignoni","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000146007.54092.37","article-title":"Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR","volume":"29","author":"Argani","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.5858\/arpa.2019-0442-RA","article-title":"Contemporary renal tumor categorization with biomarker and translational updates: a practical review","volume":"143","author":"Taylor","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00803-z_bib20","doi-asserted-by":"crossref","unstructured":"Akgul, M, Saeed, O, Levy, D, Mann, SA, Cheng, L, Grignon, DJ, et al. Morphologic and immunohistochemical characteristics of fluorescent in situ hybridization confirmed TFE3-gene fusion associated renal cell carcinoma: a single institutional cohort. Am J Surg Pathol. 2020. https:\/\/doi.org\/10.1097\/PAS.0000000000001541.","DOI":"10.1097\/PAS.0000000000001541"},{"key":"10.1038\/s41379-021-00803-z_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","article-title":"Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network","volume":"21","author":"Malouf","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-021-00803-z_bib22","doi-asserted-by":"crossref","unstructured":"Zoumpourlis, P, Genovese, G, Tannir, NM & Msaouel, P. Systemic therapies for the management of non-clear cell renal cell carcinoma: what works, what doesn't, and what the future holds. Clin Genitourin Cancer. 2020. https:\/\/doi.org\/10.1016\/j.clgc.2020.11.005.","DOI":"10.1016\/j.clgc.2020.11.005"},{"key":"10.1038\/s41379-021-00803-z_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s40425-018-0482-z","article-title":"Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders","volume":"6","author":"Boileve","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1038\/s41379-021-00803-z_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(21)00152-5","article-title":"A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial","volume":"397","author":"Pal","year":"2021","journal-title":"Lancet"},{"key":"10.1038\/s41379-021-00803-z_bib25","doi-asserted-by":"crossref","unstructured":"Thouvenin J, Kalaassen Z. Efficacy of cabozantinib in advanced MiT family translocation renal cell carcinomas. Journal of Clinical Oncology. 2021;39.","DOI":"10.1200\/JCO.2021.39.6_suppl.274"},{"key":"10.1038\/s41379-021-00803-z_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-021-00803-z_bib27","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib28","doi-asserted-by":"crossref","unstructured":"Skala SL, Wang X, Zhang Y, Mannan R, Wang L, Narayanan SP, et al. Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms. Eur Urol. 2020. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.003.","DOI":"10.1016\/j.eururo.2020.03.003"},{"key":"10.1038\/s41379-021-00803-z_bib29","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/s41379-021-00803-z_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1038\/s41379-021-00803-z_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinform"},{"key":"10.1038\/s41379-021-00803-z_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib33","first-page":"964","article-title":"Integrated proteogenomic characterization of clear","volume":"179","author":"Clark","year":"2019","journal-title":"Cell Ren Cell Carcinoma Cell"},{"key":"10.1038\/s41379-021-00803-z_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0b013e3181609914","article-title":"Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature","volume":"32","author":"Camparo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1593\/neo.131544","article-title":"Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing","volume":"15","author":"Pflueger","year":"2013","journal-title":"Neoplasia"},{"key":"10.1038\/s41379-021-00803-z_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","article-title":"MiT family translocation renal cell carcinoma","volume":"32","author":"Argani","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","article-title":"TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum","volume":"37","author":"Rao","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1309\/AJCPDTRTO2Z4UEXD","article-title":"A broad survey of cathepsin K immunoreactivity in human neoplasms","volume":"139","author":"Zheng","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-021-00803-z_bib39","doi-asserted-by":"crossref","first-page":"5974089","DOI":"10.1155\/2019\/5974089","article-title":"A Rare Partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of MED15-TFE3 fusion","volume":"2019","author":"Ye","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1038\/s41379-021-00803-z_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","article-title":"Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms","volume":"78","author":"Skala","year":"2020","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00803-z_bib41","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/s41379-021-00803-z_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.112.270207","article-title":"Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy","volume":"111","author":"Chen","year":"2012","journal-title":"Circ Res"},{"key":"10.1038\/s41379-021-00803-z_bib43","doi-asserted-by":"crossref","first-page":"152573","DOI":"10.1016\/j.prp.2019.152573","article-title":"A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt\/beta-catenin signaling pathway in breast cancer","volume":"215","author":"Li","year":"2019","journal-title":"Pathol Res Pract"},{"key":"10.1038\/s41379-021-00803-z_bib44","doi-asserted-by":"crossref","first-page":"e10528","DOI":"10.7554\/eLife.10528","article-title":"Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63","volume":"5","author":"von Grabowiecki","year":"2016","journal-title":"Elife"},{"key":"10.1038\/s41379-021-00803-z_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jmcb\/mjy036","article-title":"Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification","volume":"11","author":"Heras","year":"2019","journal-title":"J Mol Cell Biol"},{"key":"10.1038\/s41379-021-00803-z_bib46","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/jid.2015.179","article-title":"Identification of genes expressed in hyperpigmented skin using meta-analysis of microarray data sets","volume":"135","author":"Yin","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1038\/s41379-021-00803-z_bib47","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/jid.2010.5","article-title":"Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and\/or UVB","volume":"130","author":"Choi","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/s41379-021-00803-z_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1507\/endocrj.K09E-290","article-title":"Glucocorticoid-induced gene tripartite motif-containing 63 (TRIM63) promotes differentiation of osteoblastic cells","volume":"57","author":"Azuma","year":"2010","journal-title":"Endocr J"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00803-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00803-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00803-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:34:41Z","timestamp":1760229281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0893395222005737"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00803-z","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00803-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}